Skip to main content
. 2018 Apr 13;13(4):e0195897. doi: 10.1371/journal.pone.0195897

Table 3. Adverse events of special interest (FAS, n = 4005).

Preferred term Relationship to trial vaccine determined by investigator Outcome
Group 1 (Lot 1)
Troponin I increase ≥ 2 x ULN Unlikely Resolved
Wolff-Parkinson-White Syndrome Unrelated Resolved
Group 2 (Lot 2)
Troponin I increase ≥ 2 x ULN Unlikely Resolved
Supraventricular extrasystoles Unrelated Resolved
Bundle branch block right Possible Not Resolved
Tachycardia Unrelated Resolved
ECG ST Segment abnormal Unrelated Unknown
Group 3 (Lot 3)
Pericarditis Possible Resolved
Group 4 (Placebo)
Bundle branch block right Unrelated Resolved